These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26463649)

  • 1. Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum.
    van Besien K
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2035-2036. PubMed ID: 26463649
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
    Klyuchnikov E; Bacher U; Kröger NM; Hari PN; Ahn KW; Carreras J; Bachanova V; Bashey A; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Hertzberg MS; Holmberg LA; Kharfan-Dabaja MA; Klein A; Ku GH; Laport GG; Lazarus HM; Miller AM; Mussetti A; Olsson RF; Slavin S; Usmani SZ; Vij R; Wood WA; Maloney DG; Sureda AM; Smith SM; Hamadani M
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2091-2099. PubMed ID: 26253007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation in follicular lymphoma.
    Khouri IF
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):271-7. PubMed ID: 21658623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithymocyte globulin in reduced-intensity conditioning allografting: is the benefit simply in the eyes of the transplanter?
    Hamadani M
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):292-4. PubMed ID: 24394802
    [No Abstract]   [Full Text] [Related]  

  • 5. Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity.
    Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Busque L; Ahmad I; Roy J
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):951-7. PubMed ID: 22155507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy.
    van Besien K
    Hematology Am Soc Hematol Educ Program; 2009; ():610-8. PubMed ID: 20008246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
    Carella AM; Beltrami G; Lerma E; Cavaliere M; Corsetti MT
    Cancer Treat Res; 2002; 110():101-12. PubMed ID: 11908194
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
    Perales MA; Ceberio I; Armand P; Burns LJ; Chen R; Cole PD; Evens AM; Laport GG; Moskowitz CH; Popat U; Reddy NM; Shea TC; Vose JM; Schriber J; Savani BN; Carpenter PA;
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):971-83. PubMed ID: 25773017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion.
    Eefting M; de Wreede LC; Halkes CJ; von dem Borne PA; Kersting S; Marijt EW; Veelken H; Putter H; Schetelig J; Falkenburg JH
    Haematologica; 2016 Apr; 101(4):506-14. PubMed ID: 26802054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.
    Bhatt VR; Armitage JO
    Expert Opin Biol Ther; 2016; 16(1):57-66. PubMed ID: 26515478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning?
    Ringdén O; Sadeghi B
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1615-7. PubMed ID: 23022465
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis.
    Quellmann S; Schwarzer G; Hübel K; Engert A; Bohlius J
    Leukemia; 2008 Sep; 22(9):1801-3. PubMed ID: 18449206
    [No Abstract]   [Full Text] [Related]  

  • 14. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
    Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allografting or autografting for myeloma.
    Rajkumar SV; Kyle RA
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600891
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma.
    Ono Y; Mori T; Kato J; Yamane A; Shimizu T; Kikuchi T; Kohashi S; Okamoto S
    Am J Hematol; 2012 Sep; 87(9):929-31. PubMed ID: 22674621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
    Peggs KS; Sureda A; Qian W; Caballero D; Hunter A; Urbano-Ispizua A; Cavet J; Ribera JM; Parker A; Canales M; Mahendra P; Garcia-Conde J; Milligan D; Sanz G; Thomson K; Arranz R; Goldstone AH; Alvarez I; Linch DC; Sierra J; Mackinnon S;
    Br J Haematol; 2007 Oct; 139(1):70-80. PubMed ID: 17854309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin in the conditioning regimen: why not?
    Bacigalupo A
    Biol Blood Marrow Transplant; 2014 May; 20(5):597-8. PubMed ID: 24641827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.